US equities |
MU $1,088.00 ▲+4.06% NVDA $237.47 ▼-0.74% SNDK $1,692.42 ▲+1.92% SPCX $167.60 ▼-2.51% AMD $645.86 ▼-0.55% AAPL $336.67 ▲+0.91% TSLA $377.81 ▼-0.75% META $721.31 ▼-2.38%
FinancialContent

Latest News about FDA Review Extension

Recent news which mentions FDA Review Extension

U.S. FDA Extends Review By Three Months For Provention Bio's Type 1 Diabetes Candidate
Tickers PRVB
Tags General FDA Review Extension PRVB
From Benzinga
Amylyx Pharmaceuticals Shares Shoot Up As FDA Extends Review Of NDA For Neurodegenerative Disease Candidate
Tickers AMLX
Tags News AMLX FDA
From Benzinga